3 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
Follow LPS: new trials by email Literature Review of LPS trials Research Report on LPS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699 Placebo, GSK3358699, GM-CSF - Arthritis, Rheumatoid | Phase 1 | Terminated | GlaxoSmithKline | 48 | 2018-03-13 | 2020-12-02 |
| A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model PF-06282999, Placebo, LPS - Healthy | Phase 1 | Terminated | Pfizer | 23 | 2014-03-01 | 2016-08-02 |
| Response of Airway Cells to 20,000 EU of Endotoxin in Normal Adults Clinical Center Reference Endotoxin (CCRE) - Healthy Controls | Phase 1 | Terminated | University of North Carolina, Chapel Hill | 26 | 2003-08-01 | 2012-10-08 |
GlaxoSmithKline (1) · Pfizer (1) · University of North Carolina, Chapel Hill (1)
United States (2) · United Kingdom (1)
1RC1ES018417 (1), 2017 (1)